Save time and get answers to complex questions with AI chat
Alogliptin benzoate cost?What excipients are combined with ruxolitinib in apotex's medication?Testosterone enanthate expiration?Guselkumab patent expiration?Drugpatentwatch market analysis industry today?
See the DrugPatentWatch profile for Olumiant
Olumiant (brand name for baricitinib) is manufactured by Eli Lilly and Company for global markets, in collaboration with its distribution partners depending on the country.
Eli Lilly is the drug’s developer and brand owner for Olumiant and markets it through regional affiliates and licensed distributors.
Drug pricing and patent databases sometimes list different entities for specific activities (for example, marketing authorization holder vs. manufacturing site vs. patent holder). For an up-to-date, country-linked view of the rights and associated entities, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Olumiant :